Tag : AROMATASE INHIBITOR

CONFERENCE UPDATE

SEER-MHOS analysis supports the use of local estrogen therapy in breast cancer patients
Analysis of the SEER-MHOS database found that vaginal estrogen use was associated with reduced overall mortality in hormone receptor–positive (HR+) breast cancer patients, without increasing breast cancer–specific mortality. These findings may help inform discussions on the use of vaginal estrogen in patients receiving anti-hormonal treatment.